Selected scientific papers
This section contains a selection of Dr. Breggin's scientific articles spanning 1964 to the present. They can be arranged chronologically in order to facilitate an overview of his work over the years.
 
 

DocumentsDate added

Order by : Name | Date | Hits | [ Descendent ]
file icon A Case of Fluoxetine-induced Stimulant Side Effects with Suicidal Ideation... 01/02/1992
Breggin, P.R. (1992). A Case of Fluoxetine-induced Stimulant Side Effects with Suicidal Ideation Associated with a Possible Withdrawal Syndrome ("Crashing").  International Journal of Risk & Safety in Medicine, 3, 325-328.
file icon Electroshock: Scientific, Ethical, & Political Issues (1998) 01/01/1998
"Electroshock: Scientific, Ethical, and Political Issues." International Journal of Risk & Safety In Medicine, 11:5-40, 1998.
file icon A dangerous assignment (2001) 03/01/2001
"A dangerous assignment," In Howard Rosenthal (Ed.). Favorite Counseling and Therapy Homework Assignments: Leading Therapists Share their Most Creative Strategies, pp. 58-59. Philadelphia: Brunner Routledge, 2001.
file icon The Rights of Children and Parents Regarding Child Diagnosis and Drugging 04/26/2014
The Rights of Children and Parents In Regard to Children Receiving Psychiatric Diagnoses and Drugs. Children & Society, 28, (2014) pp. 231-241


Peter R. Breggin, MD


Based on the author's extensive clinical, forensic and research experience, this article addresses the scientific and moral question of whether it is ever in the best interests of a child to be given a psychiatric drug. The focus is on the diagnosis Attention Deficit Hyperactivity Disorder (ADHD) and stimulant drugs, and on the diagnosis Bipolar Disorder and antipsychotic (neuroleptic) drugs. The conclusion is that we should work towards a prohibition against giving psychiatric drugs to children, and instead focus on safe and effective alternative ways of meeting the needs of children within their families, schools and society. © 2014 John Wiley & Sons Ltd and National Children's Bureau.

file icon From Prozac to Ecstasy: implications of new evidence for drug-induced brain damage (2001) 01/01/2001
"From Prozac to Ecstacy: The Implication of New Evidence for Drug-Induced Brain Damage." Ethical Human Sciences and Services, 3: 3-5, 2001.
file icon Empowering social work in the era of biological psychiatry (2001) 04/01/2001
"Empowering Social Work in the Era of Biological Psychiatry." (2001) [The annual Ephraim Lisansky ecture of the University of Maryland School of Social Work.] Ethical Human Sciences and Services, :197-206.
file icon What pyschologists and psychiatrists need to know about ADHD and stimulants 05/01/2000
"What Psychologists and Psychotherapists Need to Know About ADHD and Stimulants." Changes: An International Journal of Psychology and Psychotherapy, 18:13-23, Spring 2000.
file icon The FDA should test the safety of ECT machines 07/13/2010
International Journal of Risk & Safety in Medicine 22 (2010) 89-92.
 
Peter R. Breggin
 
Abstract: Electroconvulsive therapy (ECT) and the machines that deliver it have never been tested for safety and efficacy in order to receive approval from the FDA. The American Psychiatric Association and ECT advocates protested when the FDA took steps to classify the machines as posing “an unreasonable risk of illness or injury”, which would have required their testing before approval. Without requiring this testing, the FDA is now preparing to classify the treatment and the machines as safe. This article reviews evidence demonstrating that ECT is very harmful to the brain and mind, and concludes that the FDA should demand the usual testing, starting with animals, that is required before psychiatric treatments and machines are approved for marketing and use.
file icon Campaigns against racist federal programs by the ICSPP (1995/96) 01/01/1995
"Campaigns against racist federal programs by the Center for the Study of Psychiatry and Psychology." Journal of African American Men 1:No. 3, 3-22. Winter 1995/96.
file icon What cost leukotomy? 01/01/1983
"What Cost Leukotomy?" (letter) American Journal of Psychiatry 140:1101, 1983.
<< Start < Prev 1 2 3 4 5 6 7 8 Next > End >>
Results 11 - 20 of 76

 

WARNING!

Most psychiatric drugs can cause withdrawal reactions, sometimes including life-threatening emotional and physical withdrawal problems. In short, it is not only dangerous to start taking psychiatric drugs, it can also be dangerous to stop them. Withdrawal from psychiatric drugs should be done carefully under experienced clinical supervision. Methods for safely withdrawing from psychiatric drugs are discussed in Dr. Breggin's new book, Psychiatric Drug Withdrawal: A Guide for Prescribers, Therapists, Patients, and Their Families.